Down Syndrome: Monitoring, Features, and Pathophysiology — Vocabulary

Monitoring and care planning for children with Down syndrome aims to support development and health. Key monitoring areas include congenital heart defects, vision and hearing problems, gastrointestinal issues, and mobility. Care plans focus on supporting developmental needs, providing referrals to specialists, initiating therapies (speech, physical, occupational), and educating families on prognosis and resources.

Common comorbidities associated with Down syndrome include congenital heart disease, immune deficiency, sleep apnea, leukemia, and a higher lifetime risk of Alzheimer's disease in adulthood.

The primary genetic cause of Down syndrome is Trisomy 21, an extra copy of chromosome 21. This can manifest as complete trisomy 21, translocation trisomy 21, or mosaic Down syndrome. Clinical features often include a flat face, slanted/upward-angled eyes, a flat nasal bridge, a large protruding tongue (macroglossia), low muscle tone (hypotonia), and a single transverse palmar crease (simian crease). Diagnostic tests include prenatal chorionic villus sampling (CVS) and amniocentesis, with postnatal confirmation by karyotype analysis.

Cellular regulation concepts relevant to pathology include hypertrophy (extincreaseincellsizeext{increase in cell size}), hyperplasia (extincreaseincellnumberext{increase in cell number}), atrophy (extdecreaseincellsizeornumberext{decrease in cell size or number}), ischemia (exttissueinjuryduetolackofoxygenatedbloodext{tissue injury due to lack of oxygenated blood}), metaplasia (extreplacementofonedifferentiatedcelltypebyanotherext{replacement of one differentiated cell type by another}), dysplasia (extabnormaldevelopmentwithpotentialprecancerouschangesext{abnormal development with potential precancerous changes}), anaplasia (extlossofdifferentiation,associatedwithmalignancyext{loss of differentiation, associated with malignancy}), and neoplasia (extnew,uncontrolledgrowthofcellsext{new, uncontrolled growth of cells}). Cell death occurs via apoptosis, necrosis, or gangrene. Prevention strategies are categorized as primary (preventing disease), secondary (early detection), and tertiary (managing complications).

Life expectancy for individuals with Down syndrome has significantly improved, often extending into the forties, fifties, and beyond with appropriate medical care and support. Nurses and healthcare providers play a crucial role in coordinating care, advocating for resources, and providing family education and emotional support.